The CoRoent® Small Interlock™ System is designed to reduce the number of steps in the ACDF procedure, maximize intraoperative visibility and versatility, while helping to minimize the intraoperative exposure.
Features:
- Zero Step Locking Mechanism: Circumferential (360˚) PEEK Locking Ledge requires no additional steps to lock the screw in place
- Large Fusion Aperture: Provides ample space for autograft and the formation of a large fusion column
- 17X14mm FOOTPRINT: The large footprint sits posterior-laterally on the hard cortical bone of the apophyseal ring, helping to maximixe stability 7˚ Lordosis
- HEIGHTS 5-12mm (1mm INCREMENTS): Multiple implant heights provide versatility to accommodate for varying patient anatomy
- Titanium Marker:The posterior marker sits 1mm from the posterior aspect of the implant providing accurate reference of A/P location
About Nuvasive
NuVasive, Inc. (NASDAQ: NUVA) based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company’s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products. NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine.
The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches.
With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus. http://www.nuvasive.com